Physician profile
Mark A Hardy
NPI 1023123593
$2,071,642.97
in general payments reported to CMS, 2019-2025
26 companies · $103K in 2025
The $103K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119K · 2020: $66K · 2021: $1.1M · 2022: $204K · 2023: $393K · 2024: $115K · 2025: $103K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $444K · Consulting Fee: $145K · Travel and Lodging: $16K · Food and Beverage: $5,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $444,122.72 |
| Consulting Fee | $144,855.00 |
| Travel and Lodging | $16,303.14 |
| Food and Beverage | $5,195.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $1,005,357.71 | 2021-2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Stryker Corporation | $422,871.84 | 2019-2025 | 7 X 23mm Citrelock Implant, Ortholoc 2 Lapifuse, Hoffmann |
| Medshape, INC. | $388,789.30 | 2022-2025 | Lapidus Correction Jig, Right, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Medartis INC. | $204,191.71 | 2021-2025 | Aptus |
| Nextremity Solutions INC. | $44,519.12 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $3,312.47 | 2019 | |
| Smith+Nephew, INC. | $508.25 | 2019-2025 | Stravix Pl, Grafix Pl |
| Integra Lifesciences Corporation | $389.81 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Trice Medical, INC. | $295.04 | 2019 | |
| Encore Medical, LP | $237.03 | 2021-2022 | |
| Kerecis Limited | $143.04 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $141.10 | 2025 | Hawkone |
| Angiodynamics, INC. | $118.06 | 2022 | |
| Nevro Corp. | $117.62 | 2023 | Senza |
| Treace Medical Concepts, INC. | $111.90 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexus Medical Technologies LLC | $98.65 | 2025 | |
| Globus Medical, INC. | $95.33 | 2019 | |
| Arteriocyte Medical Systems, INC. | $90.56 | 2025 | Magellan |
| Organogenesis INC. | $78.57 | 2020-2023 | Puraply |
| Biopoly LLC | $55.90 | 2024 | |
| Accufix Surgical INC. | $31.02 | 2022 | |
| Paragon 28, INC. | $27.11 | 2019 | |
| Orthofix Medical, INC. | $19.44 | 2025 | Truelok |
| Osteocentric Technologies, INC. | $18.40 | 2020 | |
| Osteomed LLC | $13.33 | 2019 | |
| Arthrosurface Incorporated | $10.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hardy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.